Landauer (LDR) 10-Q 11 Aug 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Jun. 30, 2014	Jul. 29, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Jun-14	'
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2014	'
Entity Registrant Name	'LANDAUER INC	'
Trading Symbol	'ldr	'
Entity Central Index Key	'0000825410	'
Current Fiscal Year End Date	'--09-30	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Accelerated Filer	'
Entity Well-known Seasoned Issuer	'No	'
Entity Current Reporting Status	'Yes	'
Entity Common Stock, Shares Outstanding	'	9,551,378

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Jun. 30, 2014	Sep. 30, 2013
In Thousands, unless otherwise specified
ASSETS	'	'
Cash and cash equivalents	$11,154	$11,184
Receivables, net of allowances of $1,030 and $600 respectively	34,750	38,419
Inventories	7,734	9,539
Prepaid income taxes	6,383	3,132
Prepaid expenses and other current assets	5,305	4,019
Current assets	65,326	66,293
Property, plant and equipment, at cost	105,761	107,446
Accumulated depreciation and amortization	-57,369	-55,514
Net property, plant and equipment	48,392	51,932
Equity in joint ventures	23,744	23,942
Goodwill	44,645	84,436
Intangible assets, net of accumulated amortization of $37,543 and $13,604, respectively	14,663	37,161
Dosimetry devices, net of accumulated depreciation of $10,899 and $9,472, respectively	5,409	5,798
Other assets	20,539	7,271
Assets	222,718	276,833
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Accounts payable	5,611	6,310
Dividends payable	5,380	5,419
Deferred contract revenue	16,772	13,181
Accrued compensation and related costs	6,849	8,207
Other accrued expenses	7,776	7,531
Current liabilities	42,388	40,648
Non-current liabilities:	'	'
Long-term debt	138,285	142,785
Pension and postretirement obligations	13,588	13,047
Deferred income taxes	656	9,817
Other non-current liabilities	1,418	915
Non-current liabilities	153,947	166,564
Stockholders’ equity:	'	'
Preferred stock, $.10 par value per share, authorized 1,000,000 shares; none issued	'	'
Common stock, $.10 par value per share, authorized 20,000,000 shares; 9,616,579 and 9,575,926 issued and outstanding at June 30, 2014 and September 30, 2013 respectively	962	958
Additional paid in capital	40,392	39,465
Accumulated other comprehensive loss	-4,360	-4,456
(Accumulated deficit) retained earnings	-12,299	32,012
Landauer, Inc. stockholders' equity	24,695	67,979
Noncontrolling interest	1,688	1,642
Stockholders' equity	26,383	69,621
Liabilities and Stockholders’ Equity	$222,718	$276,833

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Sep. 30, 2013
In Thousands, except Share data, unless otherwise specified
Consolidated Balance Sheets [Abstract]	'	'
Receivables, allowances	$1,030	$600
Intangible assets, accumulated amortization	37,543	13,604
Dosimetry devices, accumulated depreciation	$10,899	$9,472
Preferred stock, par value	$0.10	$0.10
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$0.10	$0.10
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	9,616,579	9,575,926
Common stock, shares outstanding	9,616,579	9,575,926

Consolidated_Statements_Of_Ope

Consolidated Statements Of Operations (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Consolidated Statements Of Operations [Abstract]	'	'	'	'
Service revenues	$31,013	$31,591	$95,890	$95,593
Product revenues	3,753	4,989	16,135	14,750
Net revenues	34,766	36,580	112,025	110,343
Costs and expenses:	'	'	'	'
Service costs	16,149	15,474	46,393	44,645
Product costs	1,830	2,490	8,138	6,932
Total cost of sales	17,979	17,964	54,531	51,577
Selling, general, and administrative	13,805	12,550	41,902	38,519
Goodwill and intangible assets impairment charge	62,188	22,700	62,188	22,700
Acquisition, reorganization and nonrecurring costs	1,558	142	1,778	442
Costs and expenses	95,530	53,356	160,399	113,238
Operating loss	-60,764	-16,776	-48,374	-2,895
Equity in income of joint ventures	256	471	1,364	2,555
Interest expense, net	-817	-1,154	-2,684	-3,268
Other (loss) income, net	-22	112	7	431
Loss before taxes	-61,347	-17,347	-49,687	-3,177
Income tax (benefit) expense	-25,030	-3,748	-21,580	146
Net loss	-36,317	-13,599	-28,107	-3,323
Less: Net income attributed to noncontrolling interest	309	154	471	400
Net loss attributed to Landauer, Inc.	($36,626)	($13,753)	($28,578)	($3,723)
Net loss per share attributable to Landauer, Inc. shareholders:	'	'	'	'
Basic & diluted	($3.86)	($1.46)	($3.02)	($0.40)
Weighted average shares outstanding - basic & diluted	9,482	9,439	9,466	9,402

Consolidated_Statements_Of_Com

Consolidated Statements Of Comprehensive (Loss) Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Net (loss) income	($36,317)	($13,599)	($28,107)	($3,323)
Other comprehensive income:	'	'	'	'
Defined benefit pension and postretirement plans activity, net of tax	46	68	257	204
Foreign currency translation adjustment	-294	-654	-190	-2,833
Comprehensive (loss) income	-36,565	-14,185	-28,040	-5,952
Landauer, Inc. [Member]	'	'	'	'
Net (loss) income	-36,626	-13,753	-28,578	-3,723
Other comprehensive income:	'	'	'	'
Defined benefit pension and postretirement plans activity, net of tax	46	68	257	204
Foreign currency translation adjustment	-314	-610	-161	-2,798
Comprehensive (loss) income	-36,894	-14,295	-28,482	-6,317
Non-Controlling Interest [Member]	'	'	'	'
Net (loss) income	309	154	471	400
Other comprehensive income:	'	'	'	'
Foreign currency translation adjustment	20	-44	-29	-35
Comprehensive (loss) income	$329	$110	$442	$365

Consolidated_Statement_Of_Stoc

Consolidated Statement Of Stockholders' Equity (USD $)	Common Stock [Member]	Additional Paid In Capital [Member]	Accumulated Other Compre-hensive (Loss) Income [Member]	(Accumulated Deficit) Retained Earnings [Member]	Non-Controlling Interest [Member]	Total
In Thousands, except Share data
Balance at Sep. 30, 2013	$958	$39,465	($4,456)	$32,012	$1,642	$69,621
Balance, shares at Sep. 30, 2013	9,575,926	'	'	'	'	9,575,926
Stock-based compensation arrangements	4	927	'	'	'	931
Stock-based compensation arrangements, shares	40,653	'	'	'	'	'
Dividends	'	'	'	-15,733	-396	-16,129
Net (loss) income	'	'	'	-28,578	471	-28,107
Foreign currency translation adjustment	'	'	-161	'	-29	-190
Defined benefit pension and postretirement plans activity, net of tax	'	'	257	'	'	257
Balance at Jun. 30, 2014	962	40,392	-4,360	-12,299	1,688	26,383
Balance, shares at Jun. 30, 2014	9,616,579	'	'	'	'	9,616,579
Balance at Mar. 31, 2014	'	'	'	'	'	'
Net (loss) income	'	'	'	'	309	-36,317
Foreign currency translation adjustment	'	'	'	'	20	-294
Defined benefit pension and postretirement plans activity, net of tax	'	'	'	'	'	46
Balance at Jun. 30, 2014	'	'	'	'	$1,688	$26,383
Balance, shares at Jun. 30, 2014	'	'	'	'	'	9,616,579

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:	'	'
Net loss	($28,107)	($3,323)
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	11,607	10,860
Goodwill and other intangible impairment charge	62,188	22,700
Equity in income of joint ventures	-1,364	-2,555
Dividends from joint ventures	1,340	1,891
Stock-based compensation and related net tax benefits	1,066	2,293
Current and long-term deferred taxes, net	-21,973	-5,531
Gain on sale, disposal and abandonment of fixed assets	-35	'
Gain on investments	-369	-118
Changes in operating assets and liabilities:	'	'
Decrease in accounts receivable, net	3,815	305
Increase in prepaid taxes	-3,247	-1,349
Increase in other operating assets, net	-227	-3,479
Increase (decrease) in accounts payable and other accrued liabilities	1,379	-1,157
Increase (decrease) in other operating liabilities, net	608	-1,073
Net cash provided by operating activities	26,681	19,464
Cash flows used by investing activities:	'	'
Acquisition of property, plant and equipment	-3,056	-8,135
Acquisition of joint ventures and businesses, net of cash acquired	-1,800	'
Other investing activities, net	-1,037	-1,855
Net cash used by investing activities	-5,893	-9,990
Cash flows (used) provided by financing activities:	'	'
Net borrowings on revolving credit facility	-51	'
Long-term borrowings - loan	27,500	19,600
Long-term borrowings - repayment	-32,000	-21,387
Dividends paid to stockholders	-15,771	-15,658
Other financing activities, net	-500	-460
Net cash used by financing activities	-20,822	-17,905
Effects of foreign currency translation	4	-205
Net decrease in cash and cash equivalents	-30	-8,636
Opening balance - cash and cash equivalents	11,184	17,633
Ending balance - cash and cash equivalents	11,154	8,997
Accrued capital spending included in accounts payable and other accrued liabilities	$308	$291

Basis_Of_Presentation_And_Cons

Basis Of Presentation And Consolidation	9 Months Ended
	Jun. 30, 2014
Basis Of Presentation And Consolidation [Abstract]	'
Basis Of Presentation And Consolidation	'
	(1)Basis of Presentation and Consolidation
	As used herein, the “Company” or “Landauer” refers to Landauer, Inc. and its subsidiaries.
	These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K/A for the fiscal year ended September 30, 2013 and other financial information filed with the Securities and Exchange Commission (the “SEC”).
	The accounting policies followed by the Company are set forth in the Company’s Annual Report on Form 10-K/A for the fiscal year ended September 30, 2013.  There have been no changes to the accounting policies for the nine month period ended June 30, 2014.
	The results of operations for the three and nine month periods ended June 30, 2014 are not necessarily indicative of the results to be expected for the full fiscal year. The September 30, 2013 balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.
	The three and nine month periods ended June 30, 2014 include the correction of certain errors relating to prior periods. The Company recorded adjustments to correct the timing of revenue recognition in accordance with contractually established terms and conditions.  The amounts recorded out-of-period include an increase in the pre-tax loss of $1.3 million for the third fiscal quarter ended June 30, 2014 and an increase in the pre-tax loss of $0.9 million for nine month period ended June 30, 2014. The Company does not believe these corrections to be material to any current or prior interim or annual periods.
	In the opinion of  management, the accompanying unaudited consolidated financial statements include all adjustments necessary for a fair statement of such financial statements.  Certain reclassifications have been made in the financial statements for comparative purposes.  These reclassifications have no effect on the results of operations or financial position of the Company.
	Revision of Prior Period Financial Statements
	In connection with the preparation of the consolidated financial statements for the second quarter of fiscal 2014, the Company identified an error in the treatment of accrued additions for property, plant and equipment in the Consolidated Statements of Cash Flows.  This error resulted in an understatement of net cash provided by operating activities and net cash used in investing activities in the third quarter of fiscal 2013 and the first quarter of fiscal 2014.  In addition, the Company identified an error in its Consolidated Statement of Cash Flows which affected the third quarter of fiscal 2013.  This error related to the classification of debt financing fees and resulted in an understatement of net cash provided by operating activities and net cash used by financing activities.  In connection with the preparation of the consolidated financial statements for the third quarter of fiscal 2014, the Company identified an error related to the classification of unrealized gains or losses on investments in the Consolidated Statements of Cash Flows.  This error resulted in an overstatement of net cash provided by operating activities and net cash used in investing activities in each of the quarters of fiscal 2014 and the third fiscal quarter of 2013, as well as the year-end consolidated financial statements for the fiscal years ended September 30, 2013 and 2012.  In accordance with accounting guidance presented in ASC 250-10 and SEC Staff Accounting Bulletin No. 99, Materiality, the Company assessed the materiality of these errors and concluded that they were not material to any of the Company’s previously issued financial statements. The Company will revise its previously issued financial statements to correct for these errors. These revisions did not impact the Company’s Consolidated Statements of Operations or Consolidated Balance Sheets for any of these periods.
	The following tables present the effect of this correction on the Company’s Consolidated Statements of Cash Flows for:
		Six Months Ended
		31-Mar-14
	(Dollars in Thousands)	As Previously Reported		Adjustment		As Revised
	Cash flows from operating activities:
	(Gain) loss on investments	$	-	$	-203	$	-203
	Net cash provided by operating activities		20,164		-203		19,961
	Cash flows used by investing activities:
	Other investing activities, net		-840		203		-637
	Net cash used by investing activities		-5,055		203		-4,852
		Three Months Ended
		31-Dec-13
	(Dollars in Thousands)	As Previously Reported		Adjustment		As Revised
	Cash flows from operating activities:
	(Gain) loss on investments	$	-	$	-146	$	-146
	(Decrease) increase in accounts payable and other accrued liabilities		-3,502		174		-3,328
	Net cash provided by operating activities		9,954		28		9,982
	Cash flows used by investing activities:
	Acquisition of property, plant and equipment		-1,071		-174		-1,245
	Other investing activities, net		-719		146		-573
	Net cash used by investing activities		-3,590		-28		-3,618
		Year Ended
		30-Sep-13
	(Dollars in Thousands)	As Previously Reported		Adjustment		As Revised
	Cash flows from operating activities:
	(Gain) loss on investments	$	-	$	-282	$	-282
	Net cash provided by operating activities		25,750		-282		25,468
	Cash flows used by investing activities:
	Other investing activities, net		-2,151		282		-1,869
	Net cash used by investing activities		-11,296		282		-11,014
		Nine Months Ended
		30-Jun-13
	(Dollars in Thousands)	As Previously Reported		Adjustment		As Revised
	Cash flows from operating activities:
	(Gain) loss on investments	$	-	$	-118	$	-118
	(Increase) decrease in other operating assets, net		-3,679		200		-3,479
	(Decrease) increase in accounts payable and other accrued liabilities		-4,006		2,849		-1,157
	Net cash provided by operating activities		16,533		2,931		19,464
	Cash flows used by investing activities:
	Acquisition of property, plant and equipment		-5,286		-2,849		-8,135
	Other investing activities, net		-1,973		118		-1,855
	Net cash used by investing activities		-7,259		-2,731		-9,990
	Cash flows used by financing activities:
	Other financing activities, net		-260		-200		-460
	Net cash used by financing activities		-17,705		-200		-17,905
		Year Ended
		30-Sep-12
	(Dollars in Thousands)	As Previously Reported		Adjustment		As Revised
	Cash flows from operating activities:
	(Gain) loss on investments	$	-	$	-317	$	-317
	Net cash provided by operating activities		36,840		-317		36,523
	Cash flows used by investing activities:
	Other investing activities, net		-880		317		-563
	Net cash used by investing activities		-125,456		317		-125,139

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	9 Months Ended
	Jun. 30, 2014
Recent Accounting Pronouncements [Abstract]	'
Recent Accounting Pronouncements	'
	(2)Recent Accounting Pronouncements
	In February 2013, the FASB issued new guidance on the presentation of comprehensive income. This guidance requires reclassification adjustments from other comprehensive income to be presented either in the financial statements or in the notes to the financial statements. The standard would not change the current requirements for reporting net income or other comprehensive income in financial statements. However, the guidance would require an entity to provide enhanced disclosures to present separately by component reclassifications out of accumulated other comprehensive income. This guidance was adopted by the Company in the first quarter of fiscal 2014.  The adoption did not have a material impact on its consolidated financial statements.
	In March 2013, the FASB issued an accounting update that clarifies the applicable guidance for the release of the cumulative translation adjustment when an entity ceases to have a controlling financial interest in a subsidiary or a group of assets that is a business within a foreign entity.  The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice.  This guidance was adopted by the Company in the first quarter of fiscal 2014.  The adoption did not have a material impact on its consolidated financial statements.
	In July 2013, the FASB issued new guidance to reduce the diversity in presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists. This requires an unrecognized tax benefit to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with certain exceptions listed in the guidance.  This guidance is effective for the Company in the first quarter of fiscal 2015.  The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.
	In April 2014, the FASB issued new guidance related to the definition of a discontinued operation and requires new disclosure of both discontinued operations and certain other disposals that do not meet the definition of a discontinued operation.  This new guidance is effective for annual periods beginning on or after December 15, 2014 and interim periods within those years.  Beginning in the first quarter of fiscal 2016 the Company will apply the new guidance, as applicable, to future discontinued operations and certain other disposals that do not meet the definition of a discontinued operation.  The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.
	In May 2014, the FASB issued new guidance for recognizing revenue from contracts with customers, which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will supersede most current revenue recognition guidance.  This guidance is effective for the Company in the first quarter of fiscal 2017.  Early adoption is not permitted.  The effects of this guidance on our financial position, results of operations and cash flows are not yet known.
	In June 2014, the FASB issued new guidance on accounting for share-based payments requiring a specific performance target to be achieved in order for employees to become eligible to vest in the awards when that performance target may be achieved after the requisite service period for the award.  This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period for which the requisite service has already been rendered.  This guidance is effective for the Company in the first quarter of fiscal 2016.  Early adoption is permitted.  The Company is currently evaluating the impact that adoption of this guidance will have on its consolidated financial statements.

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Jun. 30, 2014
Fair Value Measurements [Abstract]	'
Fair Value Measurements	'
	(3)Fair Value Measurements
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in a principal or most advantageous market.  Fair value is a market-based measurement that is determined based on inputs, which refer broadly to assumptions that market participants use in pricing assets or liabilities.  A fair value hierarchy with three tiers has been established to prioritize the inputs to valuation techniques used to measure fair value.  The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs.  Level 1 inputs include quoted prices in active markets for identical assets and liabilities.  Level 2 inputs consist of observable inputs other than quoted prices in active markets or indirectly observable through corroboration with observable market data.  Level 3 inputs are not observable in the market and include management’s own judgments about the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances.
	As of June  30, 2014 and September 30, 2013, the Company’s financial assets measured and recorded at fair value on a recurring basis were comprised of investments in trading securities, which are reported in other long-term assets.  The investments are held in a Rabbi trust for benefits under the Company’s deferred compensation plan.  Under the plan, participants designate investment options to serve as the basis for measurement of the notional value of their accounts.  The investments include a money market fund and mutual funds that are publicly traded.  The fair values of the shares or underlying securities of these funds are based on quoted market prices and, therefore, are categorized as Level 1 in the fair value hierarchy.
	Financial assets measured at fair value on a recurring basis are summarized below:
		Fair Value Measurements at June 30, 2014 Using
		Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs
		(Level 1)				(Level 3)
	Asset Category
	Cash equivalents	$	110	$	-	$	-
	Mutual funds		3,673		-		-
	Total financial assets at fair value	$	3,783	$	-	$	-
		Fair Value Measurements at September 30, 2013 Using
		Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs
		(Level 1)				(Level 3)
	Asset Category
	Cash equivalents	$	55	$	-	$	-
	Mutual funds		2,922		-		-
	Total financial assets at fair value	$	2,977	$	-	$	-
	As of June  30, 2014, the carrying amount of the Company’s long-term debt, which is categorized as Level 2 in the fair value hierarchy, approximated fair value as the stated interest rates were variable in relation to prevailing market rates.
	As discussed in Note 6, the Company recorded impairment charges related to the IZI Medical Products reporting unit during the third quarter of fiscal 2014.  Intangible assets related to customer lists, tradenames and patents were written down to their fair value of $3,000 as of June 30, 2014, resulting in a non-cash pre-tax impairment charge of $20,820.The fair values of the intangible assets are based on forecasted revenues associated with the customer lists, tradenames and patents.  In addition, the Company recorded a $41,368 non-cash pretax charge to reduce the carrying value of goodwill in the IZI Medical Products reporting unit to an implied fair value of $0 as of June 30, 2014.  Level 3 inputs were used to estimate these nonrecurring fair value measurements.  The fair values were determined using discounted cash flow models based on assumptions and projections of revenues and expenses.  Key assumptions included a terminal growth rate of 3% and discount rates ranging from 11.5% to 12.5%.

Loss_Per_Common_Share

Loss Per Common Share	9 Months Ended
	Jun. 30, 2014
Loss Per Common Share [Abstract]	'
Loss Per Common Share	'
	(4)Loss per Common Share
	Basic net loss per share was computed by dividing net loss available to common stockholders for the period by the weighted average number of shares of common stock outstanding during the period.  Diluted net loss per share was computed by dividing net loss available to common stockholders for the period by the weighted average number of shares of common stock that would have been outstanding assuming dilution from stock-based compensation awards during the period.  As the Company had a net loss in each of the periods presented, basic and diluted net loss per common share are the same.
	The following table sets forth the computation of net loss per share:
		Three Months Ended					Nine Months Ended
		June 30,					June 30,
	(Dollars in Thousands, Except per Share)	2014			2013		2014		2013
	Basic Net Loss per Share:
	Net loss available to common stockholders	$	-36,626		$	-13,753	$	-28,578	$	-3,723
	Weighted average shares outstanding - Basic & Diluted		9,482			9,439		9,466		9,402
	Net loss per share - Basic & Diluted	$	-3.86		$	-1.46	$	-3.02	$	-0.4
	In periods where losses are recorded, inclusion of potentially dilutive securities in the calculation would decrease the loss per common share and, therefore, these securities are not added to the weighted average number of shares outstanding.  The computations of diluted net loss per common share for the periods ended June 30, 2014 and 2013 did not include the following outstanding shares of restricted stock as well as the effects of options to acquire common stock as the inclusion of these securities would have been antidilutive:
		Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014	2013
	Effect of dilutive securities	37		37		39	44

Employee_Benefit_Plans

Employee Benefit Plans	9 Months Ended
	Jun. 30, 2014
Employee Benefit Plans [Abstract]	'
Employee Benefit Plans	'
	(5)Employee Benefit Plans
	The components of net periodic benefit cost for pension and other benefits were as follows:
	Pension Benefits	Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Interest cost	$	375	$	340	$	1,125	$	1,020
	Expected return on plan assets		-377		-365		-1,131		-1,095
	Amortization of net loss		48		109		145		325
	Net periodic benefit cost	$	46	$	84	$	139	$	250
	Other Benefits	Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Service cost	$	15	$	18	$	46	$	52
	Interest cost		13		11		38		34
	Amortization of net gain		-2		-		-8		-
	Net periodic benefit cost	$	26	$	29	$	76	$	86
	The Company, under the IRS minimum funding standards, has no required contributions to make to its defined benefit pension plan during fiscal 2014.
	The Company maintains 401(k) Retirement Savings Plans for certain employees, which may provide for employer matching contributions, and a supplemental defined contribution plan for certain executives, which provides for employer contributions at the discretion of the Company.  Amounts expensed for Company contributions under these plans during the three months ended June 30, 2014 and 2013 were $495 and $349, respectively.  Amounts expensed during the nine months ended June 30, 2014 and 2013 were $1,354 and $1,150, respectively.

Goodwill_And_Other_Intangibles

Goodwill And Other Intangibles	9 Months Ended
	Jun. 30, 2014
Goodwill And Other Intangibles [Abstract]	'
Goodwill And Other Intangibles	'
	(6)Goodwill and Other Intangibles
	During the third quarter of fiscal 2014, it became apparent that anticipated revenue and profitability trends in our IZI Medical Products reporting unit were not being achieved to the extent forecasted.  Early budget reviews also indicated future sales growth and margins may be less than expected.  We updated the forecast for our Medical Products segment based on the most recent financial results and our best estimates of future operations. The updated forecast reflects slower growth in revenues and lower margins for the Medical Products segment primarily due to anticipated continued competitive pricing pressure.  As a result, for the quarter ended June 30, 2014, the Company performed an impairment analysis with respect to the carrying value of the intangible assets and goodwill in the IZI Medical Products reporting unit.  Based on the testing performed, the Company recorded a non-cash impairment charge of $62,188, of which $41,368 related to goodwill and $20,820 related to intangible assets.
	In accordance with FASB ASC 360-10, Impairment and Disposal of Long-Lived Assets, the Company evaluated the recoverability of its long-lived assets in the IZI Medical Products reporting unit.  Based upon this evaluation, the Company determined that its intangible assets related to customer lists, tradenames and patents were impaired.  As a result, the Company recognized a non-cash pre-tax intangible asset impairment charge of $20,820.  The tax benefit associated with this charge was $8,399.
	In accordance with FASB ASC 350, Intangibles – Goodwill and Other, the Company aggregates its business components into reporting units and tests for goodwill impairment. The Medical Products segment is comprised of two reporting units – IZI Medical Products and Ilumark.  The Company tested goodwill at the IZI Medical Products reporting unit for the quarter ended June 30, 2014. Goodwill impairment is determined using a two-step process. The first step of the goodwill impairment test is to identify potential impairment by comparing the fair value of a segment with its net book value (or carrying amount), including goodwill. If the fair value of a segment exceeds its carrying amount, goodwill of the segment is considered not to be impaired and the second step of the impairment test is unnecessary. If the carrying amount of the segment exceeds its fair value, the second step of the goodwill impairment test is performed to measure the amount of the impairment loss, if any. The second step of the goodwill impairment test compares the implied fair value of the segment’s goodwill with the carrying amount of that goodwill. If the carrying amount of the segment’s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. That is, the fair value of the segment is allocated to all of the assets and liabilities of that segment (including any unrecognized intangible assets) as if the segment had been acquired in a business combination and the fair value of the segment was the purchase price paid to acquire the segment.
	Based on the result of the first step of the goodwill impairment analysis, the Company determined that the fair value of the IZI Medical Products reporting unit was less than its carrying value as of June 30, 2014 and, as such, the Company applied the second step of the goodwill impairment test to this segment. Based on the result of the second step of the goodwill impairment analysis, the Company recorded a $41,368 non-cash pretax charge to reduce the carrying value of goodwill in the IZI Medical Products reporting unit. The tax benefit associated with this charge was $16,692. The impairment charge is non-cash in nature and does not affect the Company’s liquidity. As a result of the impairment charge in our IZI Medical Products reporting unit recognized during the third quarter of fiscal 2014 and the effects of foreign currency in the Radiation Measurement segment, the carrying amount of goodwill was reduced to $44,645 as of June 30, 2014 from $84,436 as of September 30, 2013.
	During the third quarter of fiscal 2013, the Company performed an impairment analysis with respect to the carrying value of the goodwill in the IZI Medical Products reporting unit.  Based on the testing performed, the Company recorded a non-cash goodwill impairment charge of $22,700.  The tax benefit associated with this charge was $4,900.
	Changes in the carrying amount of goodwill by reportable segment for the nine months ended June 30, 2014 were as follows:
		Radiation Measurement		Medical		Medical		Total
				Physics		Products
	Balance as of September 30, 2013	$	20,456	$	22,611	$	41,369	$	84,436
	Increase related to acquisitions		-		-		1,781		1,781
	Effects of foreign currency		-199		-		-5		-204
	Goodwill impairment charges						-41,368		-41,368
	Goodwill, net as of June 30, 2014	$	20,257	$	22,611	$	1,777	$	44,645
	On December 23, 2013, the Company acquired a small German distributor.  The preliminary purchase price allocation indicates an increase in customer lists of $768, an increase in goodwill of $1,781 and an earn-out liability of $885.
	Intangible assets were as follows for the periods ended:
			30-Jun-14						30-Sep-13
		Gross		Accumulated		Intangibles Impairment		Gross		Accumulated
		Carrying		Amortization		Charge		Carrying		Amortization
		Amount						Amount
	Customer lists	$	44,794	$	32,961	$	18,657	$	43,954	$	11,639
	Trademarks and tradenames		2,176		2,051		1,498		2,154		400
	Licenses and patents		4,659		1,974		665		4,080		1,008
	Other intangibles		577		557		-		577		557
	Intangible assets	$	52,206	$	37,543	$	20,820	$	50,765	$	13,604
	Identifiable intangible assets with finite lives are amortized over their estimated useful lives.  Intangible assets amortization expenses (not including impairment) were $897 and $3,119 for the three and nine months ended June  30, 2014 and $834 and $2,533 for the three and nine months ended June  30, 2013.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive (Loss) Income	9 Months Ended
	Jun. 30, 2014
Accumulated Other Comprehensive (Loss) Income [Abstract]	'
Accumulated Other Comprehensive (Loss) Income	'
	(7)Accumulated Other Comprehensive (Loss) Income
	Accumulated elements of other comprehensive (loss) income (“AOCI”), net of tax, are included in the stockholders’ equity section of the condensed consolidated balance sheets.  Changes in each component of AOCI are as follows:
		Foreign Currency Translation Adjustments		Pension and Postretirement Plans, net of tax		Comprehensive (Loss) Income
	Balance at September 30, 2013	$	-178	$	-4,278	$	-4,456
	Other comprehensive income before reclassifications		-161		-		-161
	Amounts reclassified from accumulated other comprehensive income		-		257		257
	Net current period other comprehensive income		-161		257		96
	Balance at June 30, 2014	$	-339	$	-4,021	$	-4,360
	Reclassifications out of accumulated other comprehensive (loss) income included in the computation of net periodic benefit costs (refer to Note 5 of the Notes to Consolidated Financial Statements for additional details regarding employee benefit plans) were as follows:
	Pension and Postretirement Plans	Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Amortization of net loss	$	46	$	109	$	137	$	325
	Provision for income taxes		-		-		120		-
	Total net of tax	$	46	$	109	$	257	$	325

Credit_Facility

Credit Facility	9 Months Ended
	Jun. 30, 2014
Credit Facility [Abstract]	'
Credit Facility	'
	(8)Credit Facility
	On June 30, 2014 the Company and its subsidiaries Global Physics Solutions, Inc. and IZI Medical Products, LLC (collectively, the “Borrowers”), entered into a First Amendment to Amended and Restated Credit Agreement (the “Amendment”) with BMO Harris Bank N.A., as administrative agent (the “Administrative Agent”), and the lenders that are party thereto (collectively, the “Lenders”).  The Amendment amended the Amended and Restated Credit Agreement entered into among the Borrowers, the Administrative Agent and the Lenders on August 2, 2013 (the “Credit Agreement”).
	The Amendment amended, among other things, (i) the definition of Capital Expenditures and EBITDA and (ii) kept the fixed charge coverage ratio covenant and the leverage ratio covenant constant (1.10 to 1.00 and 3.50 to 1.00, respectively) through the remainder of the term of the Credit Agreement instead of tightening to 1.15 to 1.00 and 3.25 to 1.00, respectively, at September 30, 2015.  The Company was in compliance with all covenants as of June 30, 2014.  In connection with the Amendment, the Company paid certain amendment fees to the Lenders and certain other fees and expenses to the Administrative Agent.

Segment_Information

Segment Information	9 Months Ended
	Jun. 30, 2014
Segment Information [Abstract]	'
Segment Information	'
	(9)Segment Information
	During the first fiscal quarter of 2014, the Company changed the presentation of its reporting segments to separately disclose certain ‘corporate expenses’ that had previously been reported within the Radiation Measurement segment.  As a result, the current segment disclosures will reflect three reportable segments: Radiation Measurement, Medical Physics, Medical Products and one functional group: Corporate.  The following tables summarize financial information for each reportable segment:
		Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Revenues by segment:
	Radiation Measurement	$	24,218	$	26,383	$	81,143	$	80,035
	Medical Physics		8,175		7,903		23,943		23,090
	Medical Products		2,373		2,294		6,939		7,218
	Consolidated revenues	$	34,766	$	36,580	$	112,025	$	110,343
		Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Operating income (loss) by segment:
	Radiation Measurement	$	6,329	$	8,715	$	25,209	$	28,289
	Medical Physics		435		1,056		1,468		2,580
	Medical Products		-62,429		-22,591		-63,041		-21,617
	Corporate		-5,099		-3,956		-12,010		-12,147
	Consolidated operating loss	$	-60,764	$	-16,776	$	-48,374	$	-2,895
		June 30,		September 30,
		2014		2013
	Segment assets:
	Radiation Measurement	$	176,164	$	170,648
	Medical Physics		35,085		35,218
	Medical Products		11,469		70,967
	Consolidated assets	$	222,718	$	276,833
	As discussed in Note 6, the Company recorded impairment charges in the Medical Products segment during the fiscal third quarters of 2014 and 2013.

Related_Party_Transactions

Related Party Transactions	9 Months Ended
	Jun. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	(10)Related Party Transactions
	The Company has a minority interest in Yamasato, Fujiwara, Higa & Associates, Inc. doing business as Aquila.  The Company provides dosimetry parts to Aquila for its military contract.  The sales to and purchases from Aquila are the following for the periods ended:
		Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Sales to Aquila	$	-	$	84	$	681	$	2,842
	Purchases from Aquila		349		-		602		27
	The Company has a 50% equity interest in Nagase-Landauer, Ltd. (“Nagase”), a radiation measurement company in Japan.  The sales to and purchases from Nagase are the following for the periods ended:
		Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Sales to Nagase	$	276	$	18	$	897	$	254
	Purchases from Nagase		672		664		1,473		2,402

Basis_Of_Presentation_And_Cons1

Basis Of Presentation And Consolidation (Tables)	9 Months Ended
	Jun. 30, 2014
Basis Of Presentation And Consolidation [Abstract]	'
Schedule Of Corrections	'
		Six Months Ended
		31-Mar-14
	(Dollars in Thousands)	As Previously Reported		Adjustment		As Revised
	Cash flows from operating activities:
	(Gain) loss on investments	$	-	$	-203	$	-203
	Net cash provided by operating activities		20,164		-203		19,961
	Cash flows used by investing activities:
	Other investing activities, net		-840		203		-637
	Net cash used by investing activities		-5,055		203		-4,852
		Three Months Ended
		31-Dec-13
	(Dollars in Thousands)	As Previously Reported		Adjustment		As Revised
	Cash flows from operating activities:
	(Gain) loss on investments	$	-	$	-146	$	-146
	(Decrease) increase in accounts payable and other accrued liabilities		-3,502		174		-3,328
	Net cash provided by operating activities		9,954		28		9,982
	Cash flows used by investing activities:
	Acquisition of property, plant and equipment		-1,071		-174		-1,245
	Other investing activities, net		-719		146		-573
	Net cash used by investing activities		-3,590		-28		-3,618
		Year Ended
		30-Sep-13
	(Dollars in Thousands)	As Previously Reported		Adjustment		As Revised
	Cash flows from operating activities:
	(Gain) loss on investments	$	-	$	-282	$	-282
	Net cash provided by operating activities		25,750		-282		25,468
	Cash flows used by investing activities:
	Other investing activities, net		-2,151		282		-1,869
	Net cash used by investing activities		-11,296		282		-11,014
		Nine Months Ended
		30-Jun-13
	(Dollars in Thousands)	As Previously Reported		Adjustment		As Revised
	Cash flows from operating activities:
	(Gain) loss on investments	$	-	$	-118	$	-118
	(Increase) decrease in other operating assets, net		-3,679		200		-3,479
	(Decrease) increase in accounts payable and other accrued liabilities		-4,006		2,849		-1,157
	Net cash provided by operating activities		16,533		2,931		19,464
	Cash flows used by investing activities:
	Acquisition of property, plant and equipment		-5,286		-2,849		-8,135
	Other investing activities, net		-1,973		118		-1,855
	Net cash used by investing activities		-7,259		-2,731		-9,990
	Cash flows used by financing activities:
	Other financing activities, net		-260		-200		-460
	Net cash used by financing activities		-17,705		-200		-17,905
		Year Ended
		30-Sep-12
	(Dollars in Thousands)	As Previously Reported		Adjustment		As Revised
	Cash flows from operating activities:
	(Gain) loss on investments	$	-	$	-317	$	-317
	Net cash provided by operating activities		36,840		-317		36,523
	Cash flows used by investing activities:
	Other investing activities, net		-880		317		-563
	Net cash used by investing activities		-125,456		317		-125,139

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
	Jun. 30, 2014
Fair Value Measurements [Abstract]	'
Financial Assets Measured At Fair Value On A Recurring Basis	'
		Fair Value Measurements at June 30, 2014 Using
		Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs
		(Level 1)				(Level 3)
	Asset Category
	Cash equivalents	$	110	$	-	$	-
	Mutual funds		3,673		-		-
	Total financial assets at fair value	$	3,783	$	-	$	-
		Fair Value Measurements at September 30, 2013 Using
		Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs
		(Level 1)				(Level 3)
	Asset Category
	Cash equivalents	$	55	$	-	$	-
	Mutual funds		2,922		-		-
	Total financial assets at fair value	$	2,977	$	-	$	-

Loss_Per_Common_Share_Tables

Loss Per Common Share (Tables)	9 Months Ended
	Jun. 30, 2014
Loss Per Common Share [Abstract]	'
Computation Of Net Income (Loss) Per Share	'
		Three Months Ended					Nine Months Ended
		June 30,					June 30,
	(Dollars in Thousands, Except per Share)	2014			2013		2014		2013
	Basic Net Loss per Share:
	Net loss available to common stockholders	$	-36,626		$	-13,753	$	-28,578	$	-3,723
	Weighted average shares outstanding - Basic & Diluted		9,482			9,439		9,466		9,402
	Net loss per share - Basic & Diluted	$	-3.86		$	-1.46	$	-3.02	$	-0.4
Schedule Of Antidilutive Shares	'
		Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014	2013
	Effect of dilutive securities	37		37		39	44

Employee_Benefit_Plans_Tables

Employee Benefit Plans (Tables)	9 Months Ended
	Jun. 30, 2014
Employee Benefit Plans [Abstract]	'
Schedule Of Net Periodic Benefit Costs	'
	Pension Benefits	Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Interest cost	$	375	$	340	$	1,125	$	1,020
	Expected return on plan assets		-377		-365		-1,131		-1,095
	Amortization of net loss		48		109		145		325
	Net periodic benefit cost	$	46	$	84	$	139	$	250
	Other Benefits	Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Service cost	$	15	$	18	$	46	$	52
	Interest cost		13		11		38		34
	Amortization of net gain		-2		-		-8		-
	Net periodic benefit cost	$	26	$	29	$	76	$	86

Goodwill_And_Other_Intangible_

Goodwill And Other Intangible (Tables)	9 Months Ended
	Jun. 30, 2014
Goodwill And Other Intangibles [Abstract]	'
Changes In The Carrying Amount Of Goodwill, By Reportable Segment	'
		Radiation Measurement		Medical		Medical		Total
				Physics		Products
	Balance as of September 30, 2013	$	20,456	$	22,611	$	41,369	$	84,436
	Increase related to acquisitions		-		-		1,781		1,781
	Effects of foreign currency		-199		-		-5		-204
	Goodwill impairment charges						-41,368		-41,368
	Goodwill, net as of June 30, 2014	$	20,257	$	22,611	$	1,777	$	44,645
Other Intangible Assets	'
			30-Jun-14						30-Sep-13
		Gross		Accumulated		Intangibles Impairment		Gross		Accumulated
		Carrying		Amortization		Charge		Carrying		Amortization
		Amount						Amount
	Customer lists	$	44,794	$	32,961	$	18,657	$	43,954	$	11,639
	Trademarks and tradenames		2,176		2,051		1,498		2,154		400
	Licenses and patents		4,659		1,974		665		4,080		1,008
	Other intangibles		577		557		-		577		557
	Intangible assets	$	52,206	$	37,543	$	20,820	$	50,765	$	13,604

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive (Loss) Income (Tables)	9 Months Ended
	Jun. 30, 2014
Accumulated Other Comprehensive (Loss) Income [Abstract]	'
Changes In Each Component Of AOCI	'
		Foreign Currency Translation Adjustments		Pension and Postretirement Plans, net of tax		Comprehensive (Loss) Income
	Balance at September 30, 2013	$	-178	$	-4,278	$	-4,456
	Other comprehensive income before reclassifications		-161		-		-161
	Amounts reclassified from accumulated other comprehensive income		-		257		257
	Net current period other comprehensive income		-161		257		96
	Balance at June 30, 2014	$	-339	$	-4,021	$	-4,360
Summary Of Reclassifications Out Of Accumulated Other Comprehensive Income (Loss)	'
	Pension and Postretirement Plans	Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Amortization of net loss	$	46	$	109	$	137	$	325
	Provision for income taxes		-		-		120		-
	Total net of tax	$	46	$	109	$	257	$	325

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Jun. 30, 2014
Segment Information [Abstract]	'
Financial Information For Each Reportable Segment	'
		Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Revenues by segment:
	Radiation Measurement	$	24,218	$	26,383	$	81,143	$	80,035
	Medical Physics		8,175		7,903		23,943		23,090
	Medical Products		2,373		2,294		6,939		7,218
	Consolidated revenues	$	34,766	$	36,580	$	112,025	$	110,343
		Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Operating income (loss) by segment:
	Radiation Measurement	$	6,329	$	8,715	$	25,209	$	28,289
	Medical Physics		435		1,056		1,468		2,580
	Medical Products		-62,429		-22,591		-63,041		-21,617
	Corporate		-5,099		-3,956		-12,010		-12,147
	Consolidated operating loss	$	-60,764	$	-16,776	$	-48,374	$	-2,895
		June 30,		September 30,
		2014		2013
	Segment assets:
	Radiation Measurement	$	176,164	$	170,648
	Medical Physics		35,085		35,218
	Medical Products		11,469		70,967
	Consolidated assets	$	222,718	$	276,833

Related_Party_Transactions_Tab

Related Party Transactions (Tables)	9 Months Ended
	Jun. 30, 2014
Related Party Transactions [Abstract]	'
Schedule Of Related Party Transactions	'
		Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Sales to Aquila	$	-	$	84	$	681	$	2,842
	Purchases from Aquila		349		-		602		27
		Three Months Ended				Nine Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Sales to Nagase	$	276	$	18	$	897	$	254
	Purchases from Nagase		672		664		1,473		2,402

Basis_Of_Presentation_And_Cons2

Basis Of Presentation And Consolidation (Narrative) (Details) (USD $)	3 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2014
Basis Of Presentation And Consolidation [Abstract]	'	'
Increase in the pre-tax loss	$1.30	$0.90

Basis_Of_Presentation_And_Cons3

Basis Of Presentation And Consolidation (Schedule Of Corrections) (Details) (USD $)	3 Months Ended	6 Months Ended	9 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2014	Jun. 30, 2014	Jun. 30, 2013	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:	'	'	'	'	'	'
(Gain) loss on investments	($146)	($203)	($369)	($118)	($282)	($317)
(Increase) decrease in other operating assets, net	'	'	-227	-3,479	'	'
(Decrease) increase in accounts payable and other accrued liabilities	-3,328	'	1,379	-1,157	'	'
Net cash provided by operating activities	9,982	19,961	26,681	19,464	25,468	36,523
Cash flows used by investing activities:	'	'	'	'	'	'
Acquisition of property, plant and equipment	-1,245	'	-3,056	-8,135	'	'
Other investing activities, net	-573	-637	-1,037	-1,855	-1,869	-563
Net cash used by investing activities	-3,618	-4,852	-5,893	-9,990	-11,014	-125,139
Cash flows (used) provided by financing activities:	'	'	'	'	'	'
Other financing activities, net	'	'	-500	-460	'	'
Net cash used by financing activities	'	'	-20,822	-17,905	'	'
As Previously Reported [Member]	'	'	'	'	'	'
Cash flows from operating activities:	'	'	'	'	'	'
(Increase) decrease in other operating assets, net	'	'	'	-3,679	'	'
(Decrease) increase in accounts payable and other accrued liabilities	-3,502	'	'	-4,006	'	'
Net cash provided by operating activities	9,954	20,164	'	16,533	25,750	36,840
Cash flows used by investing activities:	'	'	'	'	'	'
Acquisition of property, plant and equipment	-1,071	'	'	-5,286	'	'
Other investing activities, net	-719	-840	'	-1,973	-2,151	-880
Net cash used by investing activities	-3,590	-5,055	'	-7,259	-11,296	-125,456
Cash flows (used) provided by financing activities:	'	'	'	'	'	'
Other financing activities, net	'	'	'	-260	'	'
Net cash used by financing activities	'	'	'	-17,705	'	'
Adjustment [Member]	'	'	'	'	'	'
Cash flows from operating activities:	'	'	'	'	'	'
(Gain) loss on investments	-146	-203	'	-118	-282	-317
(Increase) decrease in other operating assets, net	'	'	'	200	'	'
(Decrease) increase in accounts payable and other accrued liabilities	174	'	'	2,849	'	'
Net cash provided by operating activities	28	-203	'	2,931	-282	-317
Cash flows used by investing activities:	'	'	'	'	'	'
Acquisition of property, plant and equipment	-174	'	'	-2,849	'	'
Other investing activities, net	146	203	'	118	282	317
Net cash used by investing activities	-28	203	'	-2,731	282	317
Cash flows (used) provided by financing activities:	'	'	'	'	'	'
Other financing activities, net	'	'	'	-200	'	'
Net cash used by financing activities	'	'	'	($200)	'	'

Fair_Value_Measurements_Narrat

Fair Value Measurements (Narrative) (Details) (USD $)	9 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Fair valie of intangible assets	$3,000,000	'
Non-cash pretax charge to intangible assets	20,820,000	'
Terminal growth rate	3.00%	'
Medical Products [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Non-cash pretax charge to goodwill	41,368,000	22,700,000
Implied fair value of goodwill	$0	'
Minimum [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Discount rate	11.50%	'
Maximum [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Discount rate	12.50%	'

Fair_Value_Measurements_Financ

Fair Value Measurements (Financial Assets Measured At Fair Value On A Recurring Basis) (Details) (Quoted Prices in Active Markets for Identical Assets (Level 1) [Member], USD $)	Jun. 30, 2014	Sep. 30, 2013
In Thousands, unless otherwise specified
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Cash equivalents	$110	$55
Mutual funds	3,673	2,922
Total financial assets at fair value	$3,783	$2,977

Loss_Per_Common_Share_Computat

Loss Per Common Share (Computation Of Net Income (Loss) Per Share) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Loss Per Common Share [Abstract]	'	'	'	'
Net loss available to common stockholders	($36,626)	($13,753)	($28,578)	($3,723)
Weighted average shares outstanding - basic & diluted	9,482	9,439	9,466	9,402
Net loss per share - Basic & Diluted	($3.86)	($1.46)	($3.02)	($0.40)

Loss_Per_Common_Share_Schedule

Loss Per Common Share (Schedule Of Antidilutive Shares) (Details) (Restricted Stock [Member])	3 Months Ended		9 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Restricted Stock [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Effect of dilutive securities	37	37	39	44

Employee_Benefit_Plans_Narrati

Employee Benefit Plans (Narrative) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Employee Benefit Plans [Abstract]	'	'	'	'
Employer contribution for defined contribution plans	$495	$349	$1,354	$1,150

Employee_Benefit_Plans_Schedul

Employee Benefit Plans (Schedule Of Net Periodic Benefit Costs) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Pension Benefits [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Interest cost	$375	$340	$1,125	$1,020
Expected return on plan assets	-377	-365	-1,131	-1,095
Amortization of net gain	48	109	145	325
Net periodic benefit cost	46	84	139	250
Other Postretirement Benefit Plans Defined Benefit [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	15	18	46	52
Interest cost	13	11	38	34
Amortization of net gain	-2	'	-8	'
Net periodic benefit cost	$26	$29	$76	$86

Goodwill_And_Other_Intangibles1

Goodwill And Other Intangibles (Narrative) (Details) (USD $)	0 Months Ended	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Dec. 23, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 23, 2013	Sep. 30, 2013
				segment
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'	'	'	'	'
increase in goodwill	$1,781	'	'	$1,781	'	'	'
Increase in customer lists	768	'	'	'	'	'	'
Amortization expense	'	897	834	3,119	2,533	'	'
Earn-out liability	'	'	'	'	'	885	'
Reporting segments	'	'	'	3	'	'	'
Non-cash impairment charge	'	'	'	62,188	22,700	'	'
Non-cash pretax charge to intangible assets	'	'	'	20,820	'	'	'
Non-cash pretax charge tax benefit	'	'	'	8,399	'	'	'
Goodwill	'	44,645	'	44,645	'	'	84,436
Radiation Measurement [Member]	'	'	'	'	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'	'	'	'	'
Goodwill	'	20,257	'	20,257	'	'	20,456
Medical Physics [Member]	'	'	'	'	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'	'	'	'	'
Goodwill	'	22,611	'	22,611	'	'	22,611
Medical Products [Member]	'	'	'	'	'	'	'
Acquired Finite-Lived Intangible Assets [Line Items]	'	'	'	'	'	'	'
increase in goodwill	'	'	'	1,781	'	'	'
Reporting segments	'	'	'	2	'	'	'
Non-cash pretax charge to goodwill	'	'	'	41,368	22,700	'	'
Non-cash pretax charge tax benefit	'	'	'	16,692	4,900	'	'
Goodwill	'	$1,777	'	$1,777	'	'	$41,369

Goodwill_And_Other_Intangibles2

Goodwill And Other Intangibles (Changes In The Carrying Amount Of Goodwill, By Reportable Segment) (Details) (USD $)	0 Months Ended	9 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Dec. 23, 2013	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014	Sep. 30, 2013	Jun. 30, 2014
			Radiation Measurement [Member]	Medical Physics [Member]	Medical Physics [Member]	Medical Products [Member]
Goodwill [Line Items]	'	'	'	'	'	'
Goodwill	'	$84,436	$20,456	$22,611	$22,611	$41,369
Increase related to acquisitions	1,781	1,781	'	'	'	1,781
Effects of foreign currency	'	-204	-199	'	'	-5
Accumulated goodwill impairment	'	-41,368	'	'	'	-41,368
Goodwill	'	$44,645	$20,257	$22,611	$22,611	$1,777

Goodwill_And_Other_Intangibles3

Goodwill And Other Intangibles (Other Intangible Assets) (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Sep. 30, 2013
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	$52,206	$50,765
Accumulated Amortization	37,543	13,604
Intangibles Impairment	20,820	'
Customer Lists [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	44,794	43,954
Accumulated Amortization	32,961	11,639
Intangibles Impairment	18,657	'
Trademarks And Tradenames [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	2,176	2,154
Accumulated Amortization	2,051	400
Intangibles Impairment	1,498	'
Licenses And Patents [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	4,659	4,080
Accumulated Amortization	1,974	1,008
Intangibles Impairment	665	'
Other Intangibles [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	577	577
Accumulated Amortization	$557	$557

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive (Loss) Income (Changes In Each Component Of AOCI) (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Balance	($4,456)
Other comprehensive income before reclassifications	-161
Amounts reclassified from accumulated other comprehensive income	257
Net current period other comprehensive income	96
Balance	-4,360
Foreign Currency Translation Adjustments [Member]	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Balance	-178
Other comprehensive income before reclassifications	-161
Net current period other comprehensive income	-161
Balance	-339
Pension And Postretirement Plans [Member]	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'
Balance	-4,278
Amounts reclassified from accumulated other comprehensive income	257
Net current period other comprehensive income	257
Balance	($4,021)

Accumulated_Other_Comprehensiv3

Accumulated Other Comprehensive (Loss) Income (Summary Of Reclassifications Out Of Accumulated Other Comprehensive Income (Loss)) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'
Provision for income taxes	($25,030)	($3,748)	($21,580)	$146
Total net of tax	-46	-68	-257	-204
Reclassification out of Accumulated Other Comprehensive Income [Member] | Pension And Postretirement Plans [Member]	'	'	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'	'	'
Amortization of net gain	46	109	137	325
Provision for income taxes	'	'	120	'
Total net of tax	$46	$109	$257	$325

Credit_Facility_Details

Credit Facility (Details)	Jun. 30, 2014
Old Credit Agreement [Member]	'
Debt Instrument [Line Items]	'
Leverage ratio	1.15%
Fixed Charge Ratio	3.25%
New Credit Agreement [Member]	'
Debt Instrument [Line Items]	'
Leverage ratio	1.10%
Fixed Charge Ratio	3.50%

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Sep. 30, 2013
			segment
Reporting segments	'	'	3	'	'
Consolidated revenues	$34,766	$36,580	$112,025	$110,343	'
Consolidated operating loss	-60,764	-16,776	-48,374	-2,895	'
Consolidated Assets	222,718	'	222,718	'	276,833
Radiation Measurement [Member]	'	'	'	'	'
Consolidated revenues	24,218	26,383	81,143	80,035	'
Consolidated operating loss	6,329	8,715	25,209	28,289	'
Consolidated Assets	176,164	'	176,164	'	170,648
Medical Physics [Member]	'	'	'	'	'
Consolidated revenues	8,175	7,903	23,943	23,090	'
Consolidated operating loss	435	1,056	1,468	2,580	'
Consolidated Assets	35,085	'	35,085	'	35,218
Medical Products [Member]	'	'	'	'	'
Reporting segments	'	'	2	'	'
Consolidated revenues	2,373	2,294	6,939	7,218	'
Consolidated operating loss	-62,429	-22,591	-63,041	-21,617	'
Consolidated Assets	11,469	'	11,469	'	70,967
Corporate [Member]	'	'	'	'	'
Consolidated operating loss	($5,099)	($3,956)	($12,010)	($12,147)	'

Related_Party_Transactions_Nar

Related Party Transactions (Narrative) (Details) (Nagase-Landauer, Ltd. [Member])	Jun. 30, 2014
Nagase-Landauer, Ltd. [Member]	'
Related Party Transaction [Line Items]	'
Equity interest	50.00%

Related_Party_Transactions_Sch

Related Party Transactions (Schedule Of Related Party Transactions) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Aquila [Member]	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Sales to related party	'	$84	$681	$2,842
Purchases from related party	349	'	602	27
Nagase-Landauer, Ltd. [Member]	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'
Sales to related party	276	18	897	254
Purchases from related party	$672	$664	$1,473	$2,402